The lymphoma specialists at Dana-Farber/Boston Children’s
determine the best approach to treatment for each child's unique situation,
based on the type of lymphoma, the extent of the disease, the patient’s medical
condition, the patient and family’s preferences, and the most up-to-date
medical knowledge about lymphoma therapies.
Newly diagnosed, localized, diffuse large B-cell lymphoma, may
be treated with a short 9-week course of chemotherapy, including the drugs
cyclophosphamide, doxorubicin, vincristine and prednisone.
If your child has advanced diffuse large B-cell lymphoma,
treatment is the same as the treatment for Burkitt Lymphoma.
Sometimes older adolescents may be treated with the same
chemotherapy regimen that is used for adult diffuse large B-cell lymphoma. This
treatment program is called “R-CHOP”.
The cure rate for diffuse large B-cell lymphoma is very
high.
Relapsed or
refractory diffuse large B-cell lymphoma
For diffuse large B-cell lymphoma that does not respond to
initial treatment (refractory) or that comes back after treatment (relapse), treatment
recommendations are the same as for relapsed or refractory Burkitt Lymphoma.
Learn more
Learn
more about non-Hodgkin lymphoma, including:
- What are the causes and
symptoms of non-Hodgkin lymphoma?
- How is non-Hodgkin
lymphoma diagnosed and staged?
- What is the latest
research on non-Hodgkin lymphoma?